Optimization of Prescription Drug Monitoring Program to Overcome Opioid Epidemic in West Virginia

被引:4
作者
Al-Astal, Ala-Eddin Yassin [1 ]
Sodhi, Komal [2 ]
Lakhani, Hari Vishal [3 ]
机构
[1] Marshall Univ, Joan C Edwards Sch Med, Biomed Sci, Huntington, WV USA
[2] Marshall Univ, Joan C Edwards Sch Med, Surg & Biomed Sci, Huntington, WV USA
[3] Marshall Univ, Joan C Edwards Sch Med, Cardiol Surg & Biomed Sci, Huntington, WV 25701 USA
关键词
utilization; implementation; functional limitations; perceived benefits; prescription drug monitoring program; CHRONIC PAIN; ABUSE;
D O I
10.7759/cureus.22434
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The development of the Prescription Drug Monitoring Program (PDMP) led to an innovation in the healthcare organization system (HCOs). The PDMP system has been utilized in different states at various organizational levels in an effort to achieve improved health outcomes, reduce the number of prescription drug overdoses, and lighten the economic burden that follows. However, during the implementation of PDMP, there were several barriers and limitations that were discovered. Those barriers impeded the process of utilization of PDMP, such as the complex user interface and lack of training for healthcare providers. The purpose of this paper was to examine the advances and limitations in the utilization and implementation of PDMP in the US healthcare industry and develop strategies for effective use of PDMP in West Virginia. The qualitative part of this paper was a literature review. The paper referred to several peer-reviewed studies and research articles from several reliable resources, which were reached by databases or Google Scholar. A total of 44 articles were reviewed for this study. The implementation of the PDMP was influenced by benefits and barriers. This article reviewed several studies in general that demonstrated positive outcomes from the implementation of PDMP, including a reduced number of prescription drug overdoses, coordinated care for patients, and improved health outcomes. However, the barriers and limitations were not neglected, which mainly include integration of PDMP into the electronic health record (EHR) system, lack of training for the providers, and lack of basic standards for the use of PDMP. Although the new health reforms encouraged the adaption of PDMP among providers, data reporting and data interpretation still remain major concerns for assessing the health outcomes of PDMP implementation.
引用
收藏
页数:6
相关论文
共 44 条
[1]  
Ali B, 2019, J STUD ALCOHOL DRUGS, V80, P201
[2]   Development and pilot of a prescription drug monitoring program and communication intervention for pharmacists [J].
Alley, Lindsey ;
Novak, Kevin ;
Havlin, Tyler ;
Irwin, Adriane N. ;
Carson, Jody ;
Johnston, Kirbee ;
O'Kane, Nicole ;
Hartung, Daniel M. .
RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2020, 16 (10) :1422-1430
[3]   Leveraging the role of community pharmacists in the prevention, surveillance, and treatment of opioid use disorders [J].
Bach, Paxton ;
Hartung, Daniel .
ADDICTION SCIENCE & CLINICAL PRACTICE, 2019, 14 (01) :30
[4]   Assessing The Impact Of State Policies For Prescription Drug Monitoring Programs On High-Risk Opioid Prescriptions [J].
Bao, Yuhua ;
Wen, Katherine ;
Johnson, Phyllis ;
Jeng, Philip J. ;
Meisel, Zachary F. ;
Schackman, Bruce R. .
HEALTH AFFAIRS, 2018, 37 (10) :1596-1604
[5]   Effectiveness of early interventions for substance-using adolescents: findings from a systematic review and meta-analysis [J].
Carney, Tara ;
Myers, Bronwyn .
SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2012, 7
[6]   Assessment of Prescriber and Pharmacy Shopping Among the Family Members of Patients Prescribed Opioids [J].
Chua, Kao-Ping ;
Brummett, Chad M. ;
Conti, Rena M. ;
Haffajee, Rebecca L. ;
Prosser, Lisa A. ;
Bohnert, Amy S. B. .
JAMA NETWORK OPEN, 2019, 2 (05)
[7]   Advances in prescription drug monitoring program research: a literature synthesis (June 2018 to December 2019) [J].
Delcher, Chris ;
Pauly, Nathan ;
Moyo, Patience .
CURRENT OPINION IN PSYCHIATRY, 2020, 33 (04) :326-333
[8]  
Deokar AJ, 2018, J PUBLIC HEALTH MAN, V24, pS23, DOI [10.1097/phh.0000000000000704, 10.1097/PHH.0000000000000704]
[9]   Leading a Horse to Water Facilitating Registration and Use of a Prescription Drug Monitoring Program [J].
Deyo, Richard A. ;
Irvine, Jessica M. ;
Hallvik, Sara E. ;
Hildebran, Christi ;
Beran, Todd ;
Millet, Lisa M. ;
Marino, Miguel .
CLINICAL JOURNAL OF PAIN, 2015, 31 (09) :782-787
[10]   Measures Such As Interstate Cooperation Would Improve The Efficacy Of Programs To Track Controlled Drug Prescriptions [J].
Deyo, Richard A. ;
Irvine, Jessica M. ;
Millet, Lisa M. ;
Beran, Todd ;
O'Kane, Nicole ;
Wright, Dagan A. ;
McCarty, Dennis .
HEALTH AFFAIRS, 2013, 32 (03) :603-613